New Delhi : Five-year-old Bhavya knew hospitals better than playgrounds. Diagnosed with severe sickle cell disease in infancy, he endured repeated episodes of excruciating pain, hospital admissions and was dependent on blood transfusions.Every few months, his family would rush him to hospital as the inherited blood disorder disrupted what should have been a normal childhood.Today, Bhavya is back home and recovering after a stem cell transplant that doctors believe could free him from the disease.The transplant, at Apollo Hospital in April, used bone marrow donated by his sister, who was a partial match. The procedure was completed without major complications, and doctors say the transplanted cells successfully engrafted, allowing healthy blood cells to begin forming. His story is being highlighted ahead of World Sickle Cell Day on June 19 as doctors call for stronger screening, early diagnosis and access to specialised treatment.Sickle cell disease is one of the country’s most common inherited blood disorders. It affects the shape and function of red blood cells, leading to severe anaemia, recurrent pain, infections, stroke, organ damage and reduced life expectancy.The disease disproportionately affects tribal and underserved populations across central and western India. India accounts for about 10-13% of global sickle cell births. Dr Gaurav Kharya, senior consultant, pediatric haematology, oncology and immunology, said, “While advances in transplant techniques have made cure possible for a growing number of patients, prevention remains equally important.”He stressed that strengthening newborn screening, carrier detection, genetic counselling and timely referral to specialised centres can significantly reduce complications.The spotlight on the disease comes as India pursues its National Sickle Cell Anaemia Elimination Mission 2047, which aims to improve screening, diagnosis and treatment.